Koshinski Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Koshinski Asset Management's BIIB Position: Q1 2023 in Review
Koshinski Asset Management sold out of Biogen (BIIB) in Q1 2023, closing a stake of 724 shares — an estimated $200K sold.
Koshinski Asset Management first reported a position in BIIB in Q3 2018 and held it in 14 quarters. The position peaked at $489K in Q4 2019. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.
- Koshinski Asset Management reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
- Koshinski Asset Management sold 724 Biogen shares in Q1 2023, an estimated $200K.
- Koshinski Asset Management first reported a position in Biogen in Q3 2018 and held it in 14 quarters.
- Koshinski Asset Management's Biogen position peaked at $489K in Q4 2019.
- 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.
Based on Koshinski Asset Management's 13F filing for Q1 2023, filed 12 Apr 2023.